SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 14:04:20 2024-06-06 EDT | ||
| 5.14 EUR | 0.00% |
|
| Current month | -0.39% | ||
| 1 month | +4.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 5.14 | 0.00% |
| 24-06-05 | 5.14 | +1.38% |
| 24-06-04 | 5.07 | +0.20% |
| 24-06-03 | 5.06 | -1.94% |
| 24-05-31 | 5.16 | -0.96% |
Delayed Quote Deutsche Boerse AG
Last update June 06, 2024 at 02:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV9EYB |
| ISIN | DE000VV9EYB8 |
| Date issued | 2022-11-09 |
| Strike | 97.03 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.91 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.25 € |
|---|---|
| Lowest since issue | 1.63 € |
| Spread | 0.03 € |
| Spread % | 0.58% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.88
USD
Average target price
53.19
USD
Spread / Average Target
+30.12%
- Stock Market
- Certificates
- Certificat
